Skip to main content

Table 3 Difference in HbA1c, blood pressure, and BMI comparing pre- and Post-SiP

From: The impact of the COVID-19 pandemic shelter in place on glycemic control, blood pressure control, and body mass index among diabetic patients at Kaiser Permanente Northern California: a retrospective cohort study

 

Total Group

HbA1c (< 7%)

HbA1c (7-7.9%)

HbA1c (8-8.9%)

HbA1c (9-9.9%)

HbA1c (≥ 10)

HbA1c (%)

0.05 (1.17)

0.23 (0.78)

0.24 (1.05)

-0.15 (1.23)

-0.44 (1.45)

-1.13 (2.06)

BMI (kg/m2)

-0.30 (2.02)

-0.26 (2.01)

-0.39 (1.87)

-0.36 (2.02)

-0.20 (2.12)

-0.13 (2.35)

SBP (mmHg)

1.07 (15.60)

1.39 (15.53)

1.02 (15.45)

0.57 (15.70)

0.46 (16.01)

0.76 (16.52)

DBP (mmHg)

0.51 (9.49)

0.78 (9.54)

0.51 (9.42)

0.23 (9.38)

-0.02 (9.40)

-0.24 (9.67)

  1. Glycated hemoglobin (HbA1c), body mass index (BMI), systolic blood pressure (SBP), diastolic blood pressure (DBP) are shown, with difference in mean (standard deviation). Note p < 0.0001 for all variables across HbA1c groups